血必净注射液联合盐酸氨溴索治疗对老年重症肺炎患者免疫功能和炎性因子的影响Effect of Xuebijing Combined with Ambroxol Hydrochloride on Immune Function and Inflammatory Factors in Senile Severe Pneumonia
陈亮,卓越,曾宗鼎,张璐璐
摘要(Abstract):
目的观察血必净注射液联合盐酸氨溴索治疗老年重症肺炎的疗效及对免疫功能和炎性因子的影响。方法老年重症肺炎患者192例分为两组,对照组在常规治疗基础上采用盐酸氨溴索,观察组在对照组基础上采用血必净注射液。观察两组治疗14 d后的疗效和治疗前、后CD3+、CD4+、CD8+、CD4+/CD8+、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)及C反应蛋白(CRP)水平。结果与治疗前比较,观察组和对照组治疗后CD3+、CD4+及CD4+/CD8+明显升高(P <0.05),CD8+明显降低,且观察组治疗后改善程度较对照组更明显(P <0.05)。治疗后两组IL-6、IL-8、TNF-α及CRP水平均明显低于治疗前(P <0.05),且观察组治疗后IL-6、IL-8、TNF-α及CRP水平均明显低于对照组(P <0.05)。观察组总有效率明显优于对照组(P <0.05)。结论血必净注射液联合盐酸氨溴索治疗重症肺炎的临床效果较好,可提高患者的免疫功能及减轻炎症反应。
关键词(KeyWords): 重症肺炎;血必净注射液;盐酸氨溴索;免疫功能;炎性因子
基金项目(Foundation): 海南省医学科研基金资助项目(16A250038)
作者(Author): 陈亮,卓越,曾宗鼎,张璐璐
参考文献(References):
- [1]Pieralli F,Vannucchi V,De Marzi G,et al.Performance status and in-hospital mortality of elderly patients with community acquired pneumonia[J].Intern Emerg Med,2018,13(4):501-507.
- [2]Siljan WW,Holter JC,Nymo SH,er al.Cytokine responses,microbial aetiology and short-term outcome in communityacquired pneumonia[J].Eur J Clin Invest,2018,48(1):12865.
- [3]Saldías Pe?afiel F,Uribe Monasterio J,Gassmann Poniachik J,et al.Adverse event prediction in immunocompetent adult patients hospitalized with community-acquired pneumonia[J].Rev Med Chil,2017,145(6):694-702.
- [4]Xiao SH,Luo L,Liu XH,et al.Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population:A Meta-analysis[J].Medicine(Baltimore),2018,97(23):e10971.
- [5]Gupta PR.Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis:Clinical trials are the need of the hour[J].Lung India,2014,31(1):43-46.
- [6]周辉,刘峰.血必净注射液治疗慢性阻塞性肺疾病合并社区获得性肺炎的临床观察[J].中国药房,2017,28(14):1979-1981.
- [7]王云霞,宓文珍,赵丽丽,等.盐酸氨溴索应用剂量对COPD呼吸机相关肺部感染患者临床效果的影响[J].中华医院感染学杂志,2018,28(9):1338-1341.
- [8]周曙俊,王瑰,叶吉如.盐酸氨溴索联合血必净治疗老年重症肺炎患者的临床研究[J].中国中西医结合急救杂志,2017,24(5):492-496.
- [9]李桂仙,程连房,张尧.血必净注射液联合常规西药治疗重症肺炎的临床疗效[J].湖南中医药大学学报,2018,38(3):342-344.
- [10]荆珊珊,陈小侗,刘姿,等.血必净治疗重症肺炎作用机制研究进展[J].中国现代药物应用,2017,11(5):193-194.
- [11]Scicluna BP,Klein Klouwenberg PM,van Vught LA,et al.Amolecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission[J].Am J Respir Crit Care Med,2015,192(7):826-835.
- [12]?olak A,Y?lmaz C,Toprak B,et al.Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD[J].J Med Biochem,2017,36(2):122-126.
- [13]姚兰,刘亚男,侯果,等.血必净注射液在重症肺炎中对机体免疫功能的调控研究[J].湖北中医药大学学报,2017,19(5):35-38.
- [14]刁云锋,张士俊,赵万勇,等.血必净注射液对重症肺炎患者血浆IL-6和TNF-α水平的影响[J].中草药,2017,48(6):1188-1191.
- [15]沈根明,姜建平,冯淼连,等.盐酸氨溴索在辅助治疗老年肺炎中的临床应用研究[J].北京医学,2017,39(4):431-432.